Dandan Wan

1.3k total citations · 1 hit paper
16 papers, 919 citations indexed

About

Dandan Wan is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Dandan Wan has authored 16 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Dandan Wan's work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Dandan Wan is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Dandan Wan collaborates with scholars based in China and Canada. Dandan Wan's co-authors include Xiawei Wei, Yuquan Wei, Minyang Fu, Manni Wang, Jian Liu, Qin He, Man Li, Weiqi Hong, Haiying Que and Zhirong Zhang and has published in prestigious journals such as Nano Letters, ACS Nano and Journal of Controlled Release.

In The Last Decade

Dandan Wan

16 papers receiving 904 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

2022 473 citations Jian Liu, Minyang Fu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dandan Wan China	11	440	360	291	235	158	16	919
Eilam Yeini Israel	14	246 0.6×	377 1.0×	276 0.9×	413 1.8×	166 1.1×	27	1.1k
Meena Kadapakkam United States	6	190 0.4×	274 0.8×	530 1.8×	260 1.1×	74 0.5×	7	847
Karthik Tiruthani United States	11	314 0.7×	295 0.8×	279 1.0×	228 1.0×	94 0.6×	17	746
Chuanhui Han United States	15	613 1.4×	463 1.3×	399 1.4×	186 0.8×	49 0.3×	29	1.1k
Fengqin Miao China	17	304 0.7×	297 0.8×	133 0.5×	132 0.6×	142 0.9×	53	795
Zhao Yang China	16	148 0.3×	341 0.9×	243 0.8×	145 0.6×	78 0.5×	35	907
Young Seob Kim South Korea	14	458 1.0×	287 0.8×	196 0.7×	229 1.0×	90 0.6×	19	752
Mattia Laffranchi Italy	12	363 0.8×	247 0.7×	266 0.9×	73 0.3×	29 0.2×	24	747
Shiguo Zhu China	17	423 1.0×	473 1.3×	261 0.9×	69 0.3×	63 0.4×	34	950

Countries citing papers authored by Dandan Wan

Since Specialization

Citations

This map shows the geographic impact of Dandan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Wan more than expected).

Fields of papers citing papers by Dandan Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dandan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Wan. The network helps show where Dandan Wan may publish in the future.

Co-authorship network of co-authors of Dandan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Wan. A scholar is included among the top collaborators of Dandan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Wan. Dandan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Han, Xuejiao, Yuan Cheng, Dandan Wan, et al.. (2025). Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway. Cancer Communications. 45(7). 794–812. 2 indexed citations

Wan, Dandan, Liang Yu, Li Chen, et al.. (2024). Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes. Acta Pharmaceutica Sinica B. 14(10). 4577–4590. 4 indexed citations

Gao, Zirui, Dandan Wan, Min Luo, & Xiawei Wei. (2024). Application of nanomedicines in tumor immunotherapy. Journal of Molecular Cell Biology. 16(12). 3 indexed citations

Wan, Dandan, Tianxia Lan, Weiqi Hong, et al.. (2024). Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges. ACS Nano. 18(36). 24650–24681. 12 indexed citations

Chen, Li, Wenyan Ren, Hong Lei, et al.. (2023). Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses. Genes & Diseases. 11(4). 101066–101066. 1 indexed citations

Que, Haiying, Weiqi Hong, Tianxia Lan, et al.. (2022). Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal Transduction and Targeted Therapy. 7(1). 399–399. 22 indexed citations

Liu, Jian, Minyang Fu, Manni Wang, et al.. (2022). Cancer vaccines as promising immuno-therapeutics: platforms and current progress. Journal of Hematology & Oncology. 15(1). 28–28. 473 indexed citations breakdown →

Wan, Dandan, Tingfu Du, Weiqi Hong, et al.. (2021). Neurological complications and infection mechanism of SARS-CoV-2. Signal Transduction and Targeted Therapy. 6(1). 406–406. 86 indexed citations

Yu, Qianwen, Xian Tang, Wei Zhao, et al.. (2021). Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Acta Biomaterialia. 133. 244–256. 72 indexed citations

10.

Wan, Dandan, Haiying Que, Li Chen, et al.. (2021). Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response. Nano Letters. 21(19). 7960–7969. 37 indexed citations

11.

Wang, Xuhui, Sheng Yin, Man Li, et al.. (2020). Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor. Journal of Controlled Release. 321. 497–508. 12 indexed citations

12.

Rao, Jingdong, Ling Mei, Ji Liu, et al.. (2019). Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention. Acta Biomaterialia. 89. 300–312. 42 indexed citations

13.

Wan, Dandan, Yiliang Yang, Yiyao Liu, et al.. (2019). Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy. Journal of Controlled Release. 317. 43–56. 32 indexed citations

14.

Tang, Jiajing, Qiantao Wang, Qianwen Yu, et al.. (2018). A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery. Acta Biomaterialia. 83. 379–389. 61 indexed citations

15.

Yin, Sheng, Chunyu Xia, Yashi Wang, et al.. (2018). Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways. Journal of Controlled Release. 288. 148–160. 51 indexed citations

16.

Wang, Hong, Qiang Liu, Dandan Wan, et al.. (2012). BioDoser: Improved dose-estimation software for biological radiation dosimetry. Computer Methods and Programs in Biomedicine. 108(1). 402–406. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact